Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Motzer, Robert; Alekseev, Boris; Rha, Sun-Young; Porta, Camillo; Eto, Masatoshi; Powles, Thomas; Gruenwald, Viktor; Hutson, Thomas E.; Kopyltsov, Evgeny; Mendez-Vidal, Maria J.; Kozlov, Vadim; Alyasova, Anna; Hong, Sung-Hoo; Kapoor, Anil; Alonso Gordoa, Teresa; Merchan, Jaime R.; Winquist, Eric; Maroto, Pablo; Goh, Jeffrey C.; Kim, Miso; Gurney, Howard; Patel, Vijay; Peer, Avivit; Procopio, Giuseppe; Takagi, Toshio; Melichar, Bohuslav; Rolland, Frederic; De Giorgi, Ugo; Wong, Shirley; Bedke, Jens; Schmidinger, Manuela; Dutcus, Corina E.; Smith, Alan D.; Dutta, Lea; Mody, Kalgi; Perini, Rodolfo F.; Xing, Dongyuan; Choueiri, Toni K.

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Autor(en):

Motzer, Robert; Alekseev, Boris; Rha, Sun-Young; Porta, Camillo; Eto, Masatoshi; Powles, Thomas; Gruenwald, Viktor; Hutson, Thomas E.; Kopyltsov, Evgeny; Mendez-Vidal, Maria J.; Kozlov, Vadim; Alyasova, Anna; Hong, Sung-Hoo; Kapoor, Anil; Alonso Gordoa, Teresa; Merchan, Jaime R.; Winquist, Eric; Maroto, Pablo; Goh, Jeffrey C.; Kim, Miso; Gurney, Howard; Patel, Vijay; Peer, Avivit; Procopio, Giuseppe; Takagi, Toshio; Melichar, Bohuslav; Rolland, Frederic; De Giorgi, Ugo; Wong, Shirley; Bedke, Jens; Schmidinger, Manuela; Dutcus, Corina E.; Smith, Alan D.; Dutta, Lea; Mody, Kalgi; Perini, Rodolfo F.; Xing, Dongyuan; Choueiri, Toni K.

Tübinger Autor(en):

Bedke, Jens

Erschienen in:

New England Journal of Medicine (2021), Bd. 384, H. 14, S. 1289-1300

Verlagsangabe:

Massachusetts Medical Soc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1056/NEJMoa2035716

ISSN:

1533-4406